This is sponsored content issued on behalf of Voyageur Pharmaceuticals, please see full disclaimer here.
More From The Market Online
PharmAla Biotech launches educational portal for MDMA
PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.
- Jocelyn Aspa
- 2 mins
- 03 May 2024 13:12 (EDT)
Cancer-fighting pharma stock eyes 2027 regulatory approval
Theralase Technologies (TSXV:TLT), a cancer-fighting pharma stock, expands its team with two clinical research associates.
- Trevor Abes
- 3 mins
- 02 May 2024 09:27 (EDT)
PharmaDrug-PharmaTher Holdings JV submits clinical, regulatory package
Sairiyo Therapeutics, a PharmaDrug (CSE:PHRX) and PharmaTher Holdings (CSE:PHRM) joint venture, pursues a human clinical study in Australia.
- Jocelyn Aspa
- 2 mins
- 01 May 2024 13:13 (EDT)
Takeover rumours: BioNTech, Cardiol Therapeutics and Novo Nordisk in focus
Biotech has lagged behind the performance of artificial intelligence and high-tech this year, but economic conditions might signal changes.
- André Will-Laudien
- 6 mins
- 24 April 2024 13:04 (EDT)